Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.
Clin Cancer Res. 2023 Sep 15;29(18):3717-3728. doi: 10.1158/1078-0432.CCR-23-0488.
Clin Cancer Res. 2023.
PMID: 37439680
Free PMC article.
Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant.
Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T.
Schwartz G, et al.
Oncologist. 2021 Jun;26(6):467-e924. doi: 10.1002/onco.13733. Epub 2021 Mar 18.
Oncologist. 2021.
PMID: 33641211
Free PMC article.
Clinical Trial.
Item in Clipboard
Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer.
Traphagen NA, Schwartz GN, Tau S, Jiang A, Hosford SR, Goen AE, Roberts AM, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW.
Traphagen NA, et al. Among authors: romo ba.
bioRxiv [Preprint]. 2023 Mar 17:2023.03.16.532956. doi: 10.1101/2023.03.16.532956.
bioRxiv. 2023.
PMID: 36993590
Free PMC article.
Updated.
Preprint.
Item in Clipboard
TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha.
Romo BA, Karakyriakou B, Cressey L, Brauer BL, Yang H, Warren A, Johnson AL, Kettenbach AN, Miller TW.
Romo BA, et al.
Cancers (Basel). 2024 Feb 20;16(5):845. doi: 10.3390/cancers16050845.
Cancers (Basel). 2024.
PMID: 38473207
Free PMC article.
Item in Clipboard
Cite
Cite